PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy

The mineralocorticoid receptor (MR) antagonists PF 03882845 and eplerenone were evaluated for renal protection against aldosterone mediated renal disease in uninephrectomized Sprague Dawley (SD) rats maintained on a high salt diet and receiving aldosterone by osmotic mini pump for 27 days. Serum K+...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Stephen eOrena, Tristan eMaurer, Rena eEudy, Li eShe, Darla eDash, Paula eLoria, Mary Ellen eBanker, Vincent eBernardo, Meera eTugnait, Carlin eOkerberg, Jessie eQian, Carine M Boustany-Kari
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2013-10-01
Edice:	Frontiers in Pharmacology
Témata:	Albuminuria Aldosterone Hyperkalemia Chronic Kidney Disease mineralocorticoid receptor diabetic nephropathy
On-line přístup:	http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00115/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!